Novabay Pharmaceuticals Inc Il valore contabile della azione
Cos'è Il valore contabile della azione di Novabay Pharmaceuticals Inc?
Il valore contabile della azione di Novabay Pharmaceuticals Inc è 0.49
Qual è la definizione di Il valore contabile della azione?
Il valore contabile per azione è l'asset di una società meno le passività diviso per il numero di azioni in circolazione.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Il valore contabile della azione di aziende nel Health Care settore su NYSEMKT rispetto a Novabay Pharmaceuticals Inc
Cosa fa Novabay Pharmaceuticals Inc?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Aziende con il valore contabile della azione simili a Novabay Pharmaceuticals Inc
- Townsquare Media Inc ha Il valore contabile della azione di 0.49
- Kathmandu ha Il valore contabile della azione di 0.49
- NZME ha Il valore contabile della azione di 0.49
- X-Terra Resources ha Il valore contabile della azione di 0.49
- TAV Havalimanlari AS ha Il valore contabile della azione di 0.49
- 17033 ha Il valore contabile della azione di 0.49
- Novabay Pharmaceuticals Inc ha Il valore contabile della azione di 0.49
- Laramide Resources ha Il valore contabile della azione di 0.49
- Mobotix AG ha Il valore contabile della azione di 0.49
- Fab-Form Industries ha Il valore contabile della azione di 0.49
- Fireweed Zinc ha Il valore contabile della azione di 0.49
- Century Ginwa Retail ha Il valore contabile della azione di 0.49
- Eurasia Fonciere Investissements Societe Anonyme ha Il valore contabile della azione di 0.49